当前位置：
X-MOL 学术
›
Gastroenterology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial
Gastroenterology ( IF 25.7 ) Pub Date : 2024-10-23 , DOI: 10.1053/j.gastro.2024.10.020 Marius Bredon, Karine le Malicot, Christophe Louvet, Ludovic Evesque, Daniel Gonzalez, David Tougeron, Harry Sokol
Gastroenterology ( IF 25.7 ) Pub Date : 2024-10-23 , DOI: 10.1053/j.gastro.2024.10.020 Marius Bredon, Karine le Malicot, Christophe Louvet, Ludovic Evesque, Daniel Gonzalez, David Tougeron, Harry Sokol
No Abstract
中文翻译：
普拉粪杆菌与晚期胃腺癌患者对免疫检查点抑制剂的临床反应相关：PRODIGE 59-FFCD 1707-DURIGAST 试验的微生物群分析结果
无摘要
更新日期：2024-10-23
中文翻译：
普拉粪杆菌与晚期胃腺癌患者对免疫检查点抑制剂的临床反应相关：PRODIGE 59-FFCD 1707-DURIGAST 试验的微生物群分析结果
无摘要
京公网安备 11010802027423号